Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Citycon Oyj updates its guidance policy following the issuance of Capital Securities

CITYCON OYJ   Stock Exchange Release   6 February 2020 at 09.05 hrsCitycon’s Board of Directors has resolved to update Citycon’s guidance policy following the issuance of Subordinated Capital Securities (“hybrid bond”). In order to quantify the impact of hybrid bond coupons, Citycon will also provide guidance on adjusted EPRA EPS after hybrid bond coupon payments. As of 2020, Citycon will provide guidance on direct operating profit, EPRA EPS and adjusted EPRA EPS. Citycon announced on 18 November 2019 that it issued EUR 350 million green hybrid bond with an issue date of 22 November 2019.

Termination of personnel share savings plan – change in Outotec Oyj treasury shares

OUTOTEC OYJ   STOCK EXCHANGE RELEASE   FEBRUARY 6, 2020 at 9:05 AM Termination of personnel share savings plan – change in Outotec Oyj treasury shares Outotec's Board of Directors has on February 5, 2020 decided to terminate the Employee Share Savings Plan (O’Share) and on an early settlement of free shares in the pending O’Share 2017, 2018 and 2019 saving periods by a conveyance of existing Outotec shares held by the company. The decision is related to the expected merger of Outotec and Metso. An estimated number of 215,000 shares up to the maximum of 430,000 treasury shares of

Mandatory notification of trade

Reference is made to the stock exchange announcement by Axactor SE regarding the private placement of 30 million new shares. Geveran Trading Co Ltd,  a company indirectly controlled by trusts established by Mr. John Fredriksen for the benefit of his immediate family, was allocated 12,000,000 shares in the private placement at NOK 17.25 per share. Following completion of the private placement, Geveran Trading Co Ltd. will own 56,710,233 shares in Axactor, representing 30.59 % of the outstanding share capital and voting rights in the Company.

Year-End Report 1 January – 31 December 2019

”Strong ending of the year” 1 OCTOBER – 31 DECEMBER 2019 (3 MONTHS) · Net sales increased by 44 percent to SEK 988 million (685), of which organic growth amounted to 8 percent and acquired growth amounted to 35 percent. · EBITA increased by 39 percent to SEK 102 million (74), corresponding to an EBITA-margin of 10.4 percent (10.8). · Profit after tax increased by 12 percent to SEK 49 million (44). · Earnings per share amounted to SEK 1.76 (1.83). · Cash flow from operating activities amounted to SEK 175 million (92), including IFRS 16 effect of SEK 22 million (0). 1

BioGaia AB – Year-end report 2019

Comments from the CEO:“Sales in the fourth quarter of 2019 decreased by 1%, mainly due to reduced royalties from Nestlé and delivery problems. Product sales increased by 6% due to favourable growth primarily for the Paediatrics segment with a sales growth of 10%. The operating margin reached 33% despite lower sales and our increased investments in the subsidiaries MetaboGen and BioGaia Pharma.  “We started the year knowing that Nestlé had terminated the royalty agreement for Growing Up Milk and we understood that it would be difficult to achieve our normal growth rate. The plan to

I-Tech customer receives Nikkei Business Daily Awards for Excellence award for Selektope®-powered antifouling coating.

I-Tech AB’s (publ) (ticker: ITECH) largest customer, Chugoku Marine Paints, Ltd, has received prestigious recognition from the Nikkei Business Daily Awards for Excellence for their SEA PREMIER 3000 PLUS antifouling coating which is based on I-Tech’s revolutionary, barnacle-repelling active agent Selektope®.Gothenburg, Sweden – 6 February 2020: The Selektope®-powered antifouling SEA PREMIER 3000 PLUS has been recognised by the Nikkei Business Daily Awards for Excellence, in the Superior Products and Services Award category. The Nikkei is the largest financial newspaper in Japan. Now in

Hansa Biopharma Year-End Report 2019

Solid advancements in our pipeline. Agreement on a clear regulatory path with the FDA; EMA process on trackHighlights for the fourth quarter 2019 -    The ongoing review of an MAA for imlifidase in Europe by EMA is on track. Responses to the Day 120 questions were submitted on December 20, 2019. An opinion from the CHMP is expected in the second quarter of 2020.  -    Reached agreement with the FDA on a regulatory path forward for imlifidase in kidney transplantation of highly sensitized patients in the U.S. Hansa will conduct a randomized, controlled clinical study in a well-defined

Midsona - Year-end Report 2019

Strong cash flow with good underlying growth in the businessOctober–December 2019 (fourth quarter) · Net sales amounted to SEK 825 million (755), of which the concluded Alpro sales assignment was SEK 2 million (63). · EBITDA amounted to SEK 81 million (59) before items affecting comparability, corresponding to a margin of 9.8 percent (7.8). · Profit for the period amounted to SEK 35 million (33), corresponding to earnings per share of SEK 0.64 (0.71) before and after dilution. · Free cash flow amounted to SEK 103 million (44). · Midsona gained control of the acquired

Year-end Report, January-December 2019

Strong development of order intake, net sales and EBIT “I am pleased today to present another successful year for Mycronic, particularly in light of the global unrest and the slowdown in the electronics industry that characterized 2019. Order intake amounted to SEK 4,567 million, up 25 percent compared with the previous record year of 2018. In parallel, net sales increased 14 percent to SEK 4,307 million, with positive currency effects of SEK 171 million. EBIT rose 10 percent to SEK 1,124 million, with both business areas contributing to the improvement,” says Anders Lindqvist, President

Full Year Report for the period January – December 2019

Enhanced project portfolio from a successful yearKey events during the fourth quarter 2019 · BioArctic initiated a research collaboration with Eisai aimed at further studying the unique profile of the drug candidate BAN2401 · BioArctic strengthened its management team with two strategic recruitments · BioArctic and Eisai presented data on the drug candidate BAN2401 at the international CTAD conference (Clinical Trials on Alzheimer’s Disease) in San Diego · BioArctic announced results from the interim analysis of the Phase 1/2 study with SC0806, a potential treatment for

Lower organic growth with strong profit and cash flow

Fourth quarter · Net sales increased by 8% to SEK 24,946 M (23,167), with organic growth of 1% (6) and acquired net growth of 3% (3) · Strong organic growth in Americas, good growth in Global Technologies and stable in EMEA and Entrance Systems, while sales declined in Asia Pacific · Two acquisitions signed with expected combined annual sales of SEK 800 M · Tax decision in Finland reconsidered to ASSA ABLOY’s disadvantage. Estimated tax exposure of SEK 920 M, but no material effect on the Group’s net income · Operating income[1] (EBIT)[ ]increased by 8% and amounted to SEK

Traumakine update

Faron Pharmaceuticals Oy ("Faron" or the "Company")   Traumakine update  -     New trial protocol preventing concomitant corticosteroid use with Traumakine -     Company notes WHO recommendations on use of steroids in coronavirus patients   Company announcement, 06 February 2020 at 9.00 AM (EET)Inside information TURKU - FINLAND - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, today provides an update on Traumakine's clinical continuation following a meeting with the U.S. Food and Drug Administration (FDA) in

KONECRANES PLC: FINANCIAL STATEMENT RELEASE 2019

KONECRANES PLC FINANCIAL STATEMENT RELEASE 2019 February 6, 2020 9:00 am EET KONECRANES PLC: FINANCIAL STATEMENT RELEASE 2019 2019: SOLID PERFORMANCE IN A CHALLENGING MARKET  This release is a summary of Konecranes Plc’s Financial Statement Release 2019. The complete report is attached to this release in pdf format and is also available on Konecranes’ website at www.konecranes.com. Konecranes has applied IFRS 16 Leases standard since January 1, 2019. The figures for comparison period 2018 have not been restated. Please refer to note 4 for more details on the implementation of

Citycon Oyj’s Financial Statements Release for 1 January – 31 December 2019: Good operational performance

CITYCON OYJ   Stock Exchange Release 6 February 2020 at 9:00 hrs- Solid overall performance in 2019- Like-for-like net rental income grew in all business units- Total tenant sales grew by 2.6%; positive like-for-like sales development- Total footfall increased by 3.8%; positive like-for-like footfall development- Continued positive leasing spread driven by Sweden&Denmark- Loan-to-value improved to 42.4 % as a result of the successful issuance of the EUR 350 million hybrid bond OCTOBER—DECEMBER 2019 - Net rental income was EUR 53.5 million (Q4/2018: 53.7). Like-for-like

YEAR-END REPORT, January-December 2019

Solid growth and financial performanceFourth quarter of 2019                                          · Consolidated net sales increased by 10 percent to SEK 763 m (692), of which organic growth amounted to 5 percent. Acquisitions contributed by 3 percent and currency by 2 percent · Net sales in Products & Solutions amounted to SEK 554 m (516) and Installation Services to SEK 232 m (198) · EBITDA increased by 49 percent to SEK 91 m (61), whereof SEK 12 m refers to effects from IFRS 16 · Operating profit (EBIT) increased by 31 percent to SEK 62 m (47), whereof SEK 0 m refers to

Citycon’s Financial Statements and Corporate Governance Statement for 2019 published

CITYCON OYJ   Stock Exchange Release   6 February 2020 at 09:00 hrsCitycon Oyj’s Financial Review for 2019 has been published today. The Financial Review includes the Report by the Board of Directors, Consolidated Financial Statements, Parent Company Financial Statements and Auditor’s Report for the accounting period 1 January – 31 December 2019. Citycon Oyj has also published its Corporate Governance Statement 2019. The statement is prepared in accordance with the recommendations of the Finnish Corporate Governance Code published by the Finnish Securities Market Association. The

Strong operational performance in 2019 – financial targets achieved

FORTUM CORPORATION FINANCIAL STATEMENTS BULLETIN 2019 6 FEBRUARY 2020 AT 9:00 EET This release is a summary of Fortum’s Financial Statements Bulletin 2019. The complete report is attached to this release as a pdf-file. It is also available on the company's website at www.fortum.com/investors October-December 2019 · Comparable EBITDA was EUR 552 (473) million, +17% · Comparable operating profit was EUR 398 (333) million, +20% · Operating profit was EUR 444 (309) million, +44% · Share of profits of associated companies and joint ventures was EUR 65 (-44) million, mainly

Invitation to Eltel’s full year 2019 report presentation

Eltel will publish its full year and interim report for the fourth quarter 2019 on Friday 14 February 2020 at approximately 08.00 am CET. Eltel’s CEO Casimir Lindholm and CFO Petter Traaholt will host a presentation via audiocast in English starting at 10.00 am CET.The presentation will be audiocasted live on www.eltelgroup.com. For those who would like to participate in the telephone conference in connection with the presentation, the telephone numbers are: · SE: +46 8 5199 9383 · FI: +358 9 8171 0521 · UK: +44 33 3300 9268 Please, call well in advance to register. After

Introducing Duroxite[® ]200 WIRE for severe abrasive wear and moderate impact

Duroxite[® ]is SSAB’s product brand for a wide range of overlay products in the form of overlay plates, overlay pipes, overlay pins and wire rolls for welding.  Duroxite overlay products are made of abrasion resistant materials deposited on top of mild steel or Hardox[® ]wear plate to create an extremely wear resistant compound material. The latest addition to the Duroxite[® ]family is Duroxite[®]200 WIRE, which is a flux-cored welding wire for hardfacing various components.“Duroxite[®] 200 WIRE is mainly used for capping, routine maintenance or repair work. It can be welded on mild

Two projects with Wärtsilä engines delivering 292 MW will alleviate Myanmar’s power shortages

Wärtsilä Corporation, Press release, 6 February 2020 at 09.00 am EETThe technology group Wärtsilä will deliver on a fast-track basis the equipment for two power plants being urgently installed in Myanmar. During the summer of 2019, the Yangon area of the country was subjected to power cuts of up to six hours a day. In order to avoid this situation being repeated, the Myanmar government has ordered additional generating capacity to be installed and operational within a matter of months. Each plant will feature eight Wärtsilä 50SG pure gas engines delivering a combined output of 146 MW. They

SciBase to present this week at Swiss-Nordic Bio 2020

SciBase, a leading manufacturer of solutions within skin diagnostics announced today that they will present at the Swiss-Nordic Bio 2020 conference in Zurich this week.   ”I look forward to presenting an update on our progress at SciBase in Zurich. On the back of the release of Nevisense 3.0 in 2018 we have seen a significant increase in 2019 in both usage and sales of our Nevisense system for the detection of melanoma.   At the same time we’ve been pleased to see increased traction for Nevisense in the US and look forward to discussing our plans for that market.I will also present an

Year-end report 2019

Strong development of cloud services, better profitability in Nordics but continued challenges in WestOctober - December 2019 · Revenues increased by 3 percent to SEK 991 (967) million. · Adjusted EBITA amounted to SEK 48.8 (57.7) million. Items affecting comparability in the fourth quarter amounted to SEK –11.3 million related to reorganisation and acquisition related expenses.. · Profit before tax amounted to SEK 22.7 (50.3) million. Adjusted for items affecting comparability, profit before tax amounted to SEK 33.9 (50.3) million. · Profit after tax amounted to SEK 21.6 (39.

New Stena Line ferry route officially opened

On Saturday 1 February 2020 Stena Line’s new ferry route between Halmstad in Sweden and Grenaa in Denmark was officially opened. Thousands of people visited the opening ceremonies on both sides of the sea, including both the infrastructure and transport ministers of Sweden and Denmark.On Friday 31 January 2020 Stena Line closed the Varberg-Grenaa route. The day after, on Saturday 1 February the Halmstad-naa route was officially opened. The inauguration started early Saturday morning in Grenaa with almost a thousand visitors attending. The Transport minister of Denmark Benny Engelbrecht

Semcon Year-end Report 2019

Strong finish to the yearFourth quarter  · The operating income amounted to SEK 489 million (490) and the organic growth was 0.3% · The operating profit amounted to SEK 49 million (41), yielding an operating margin of 10.0% (8.4) · The profit after tax amounted to SEK 38 million (34)  · Earnings per share (EPS) after dilution amounted to SEK 2.18 (1.92)  January-December · The operating income amounted to SEK 1,858 million (1,842) and the organic growth was 0.5% · The operating profit amounted to SEK 142 million (120), yielding an operating margin of 7.6% (6.5) ·

There are no items matching the current filter
There are no more items matching the current filter
Back to top